Nanollose Limited (ASX:NC6): Microbial Cellulose Production and Nullarbor Fibre Progress in 2026

Aditi Sarkar

14 October 2026 12:24 AM AEDT

Nanollose Limited (ASX:NC6): Microbial Cellulose Production and Nullarbor Fibre Progress in 2026

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Nanollose develops microbial cellulose technology using liquid waste streams as a feedstock.
A fourth pilot fibre-production run in February 2026 produced 580kg of Nullarbor-25 and Nullarbor-30 fibres.
The company tested an improved feedstock washing and treatment process for established lyocell manufacturing equipment.
Commercial adoption depends on manufacturing economics, consistent fibre specifications and scale-up.
Its technology programme spans textile fibres and other cellulose-based material applications.

Nanollose Limited (ASX:NC6) develops microbial cellulose technology intended to turn liquid organic waste and other feedstocks into materials for textile and related applications. Its Nullarbor range focuses on producing lyocell fibre without relying on conventional wood-pulp cellulose. In 2026, a key development has been the company’s latest pilot fibre-production run and the testing of processes designed to fit established industrial manufacturing systems.

A Fourth Pilot Run Tests Manufacturing Compatibility

In February 2026, Nanollose Limited (ASX:NC6) reported completion of a fourth pilot production spin, yielding a combined 580kg of Nullarbor-25 and Nullarbor-30 fibres. The result concerned two formulations of its microbial cellulose-based fibre and represented a practical manufacturing milestone rather than evidence of full commercial-scale production.

The pilot followed preparation of a 200kg batch of microbial cellulose feedstock. The feedstock was sent to India for specification testing and fibre spinning. Nanollose Limited (ASX:NC6) also described an improved washing and treatment process developed with its cellulose supplier. According to its half-year report released in February 2026, the revised preparation removed a separate pre-processing step at the Indian manufacturing facility.

The significance of this change lies in industrial integration: a material that can be introduced into an existing lyocell production line may face fewer equipment changes than a fibre requiring entirely new production infrastructure. Nevertheless, a successful pilot does not establish manufacturing costs, customer orders or long-term commercial demand.

Why Microbial Cellulose Matters to Nullarbor

Cellulose is a principal raw material used to make regenerated fibres such as lyocell. Nanollose’s process uses microbial fermentation to create cellulose instead of drawing that input from trees. The company then processes the material into fibre that can be used in textile manufacturing. The concept links waste-based feedstock production with established downstream fibre-spinning processes.

For Nanollose Limited (ASX:NC6), the operational questions extend beyond whether a usable fibre can be produced. Repeatability between batches, production throughput, fibre quality and the availability of suitable feedstock matter to commercial manufacturing. Each must be assessed separately from a company’s stated environmental objectives. The supplied draft’s suggestion that this is a clinical healthcare business is not applicable to its textile biomaterials activities.

Research Spending and the Path to Scale

Nanollose Limited (ASX:NC6) reported receipt of an A$311,000 research and development rebate after the reporting period covered by its February 2026 half-year accounts. This receipt provides a documented financing-related development, although the rebate alone does not establish the funding required for sustained industrial-scale production.

The same release described an ongoing assessment of production economics, pricing assumptions and remaining development requirements across the company’s products. These evaluations are relevant because technical success must ultimately be tested against unit costs, production consistency and customers’ specifications. Existing factory compatibility can assist development, but does not remove operational or financial execution risks.

Key Insights

Nanollose Limited (ASX:NC6) reached a measurable manufacturing milestone in 2026 with its 580kg Nullarbor pilot fibre run. Its microbial cellulose technology offers an alternative input for regenerated textile fibres, while the practical next questions concern repeatable manufacturing, economics and commercial integration. The available disclosures support progress in pilot production, not assumptions about product revenue or widespread market adoption.

FAQs

Q: What does Nanollose develop?

A:It develops microbial cellulose technology and cellulose-based materials, including Nullarbor lyocell textile fibre.

Q: What did the 2026 pilot produce?

A:The fourth pilot run completed in February 2026 produced a combined 580kg of Nullarbor-25 and Nullarbor-30 fibre.

Q: What is the proposed feedstock advantage?

A:Microbial fermentation can use liquid waste-derived feedstocks instead of the wood pulp conventionally used to supply cellulose.

Q: Does pilot production mean the fibre is commercially established?

A:No. Pilot production demonstrates manufacturing progress; larger-scale economics, consistent output and market demand are separate considerations.

Q: What funding-related update was reported in 2026?

A:The company reported receiving an A$311,000 research and development rebate after its half-year reporting period.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.